| Inventor | Institute |
|---|---|
| John Lunec | Newcastle University |
| SKU: | 152838 |
|---|---|
| Product description: | To determine how resistance to MDM2/p53 binding antagonists might develop, SJSA-1 cells were exposed to growth inhibitory concentrations of MDM2 inhibitors, Nutlin-3, and a clonal resistant cell line generated. The p53 mediated responses of parental and resistant cell lines were compared. In contrast to the parental cell lines, p53 activation by Nutlin-3, MI-63 or ionizing radiation was not observed in the SJSA-1 derived cell lines. |
| Conditional: | No |
| Production details: | Resistant cell lines were established by exposing SJSA-1 cells to Nutlin-3. Single cell derived colonies were isolated with cloning cylinders and the clonal population expanded in culture medium containing the MDM2/p53 antagonist refreshed weekly for 60 days. Stage 1 resistant clones were then further exposed to increased concentrations of Nutlin-3 for 30 days to generate stage 2 resistant clones. |
| Cellosaurus ID: | CVCL_HG10 |
| Parental cell line: | SJSA-1 |
| Disease: | Cancer |
| Cat. #: | 152838 |
|---|---|
| Tool sub type: | Continuous |
| Unit size: | 1×10^6 cells / vial |
| Cancer types: | Sarcoma |
| Research Fields: | Apoptosis and autophagy;Cancer;Cell biology;Drug development;Genetics |
| Tissue: | Bone |
| Model: | Cancer Model |
| Growth properties: | Adherent |
| Cancer Types In Detail: | Multipotential sarcoma;Osteosarcoma |
| Format: | Frozen |
|---|---|
| Storage conditions: | Liquid Nitrogen |
| Shipping conditions: | Dry ice |
| Mycoplasma free: | Yes |
| Biosafety level: | 1 |
| References: |
TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiation. Drummond et al. 2016. Oncotarget. :. PMID: 27323823. |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.